Loading…

Bayer and CrossBay Medical Inc. announced a development and option to license agreement to develop and produce a single-handed inserter combined with Bayer's hormonal intrauterine systems (IUSs), using CrossBay's CrossGlide technology. The deal was announced on November 30, 2023.
“Partnering with CrossBay Medical has the potential to offer women an opportunity to consider the full range of contraceptive options available.”bayer.com
Summarized from public sources; check the original articles before acting on it.